Higher ERFE expression was related to all three types of survival (OS, DSS, and PFI) in adrenocortical cancer, mesothelioma, pancreatic, colon, kidney clear cell, and skin cutaneous melanoma cancers, and indicated poor outcome. The gene discussed is ERFE; the disease is adrenal cortex carcinoma.